Header Logo

Connection

KAASHIF AHMAD to Bevacizumab

Back to Details
This is a "connection" page, showing publications KAASHIF AHMAD has written about Bevacizumab.
KAASHIF AHMAD
Connection Strength
0.041
Bevacizumab
  1. Two-Year Outcomes of Infants with Stage 2 or Higher Retinopathy of Prematurity: Results from a Large Multicenter Registry. Am J Perinatol. 2020 01; 37(2):196-203.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.